Incretins Show Real-World Metabolic Gains Across Care Models

by | Jan 22, 2026 | Health

Spread the love
In adults with T2D and obesity receiving standard diabetes care, incretin therapy lowers A1c percentage, body weight, and LDL cholesterol, regardless of weight management clinic referral.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments